Rutin attenuates vancomycin‐induced renal tubular cell apoptosis via suppression of apoptosis, mitochondrial dysfunction, and oxidative stress

2019 ◽  
Vol 33 (8) ◽  
pp. 2056-2063 ◽  
Author(s):  
Shaoqi Qu ◽  
Cunchun Dai ◽  
Hui Guo ◽  
Cuncai Wang ◽  
Zhihui Hao ◽  
...  
2008 ◽  
Vol 372 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Kazuhiro Hasegawa ◽  
Shu Wakino ◽  
Kyoko Yoshioka ◽  
Satoru Tatematsu ◽  
Yoshikazu Hara ◽  
...  

2004 ◽  
Vol 33 (1) ◽  
pp. 65-69 ◽  
Author(s):  
Kriang Tungsanga ◽  
Pote Sriboonlue ◽  
Prasit Futrakul ◽  
Chatchai Yachantha ◽  
Piyaratana Tosukhowong

2015 ◽  
Vol 99 (11) ◽  
pp. 2311-2316 ◽  
Author(s):  
Swati Jain ◽  
Daniel Keys ◽  
Danica Ljubanovic ◽  
Charles L. Edelstein ◽  
Alkesh Jani

2020 ◽  
Vol 319 (6) ◽  
pp. F1015-F1026
Author(s):  
Wei Zhang ◽  
Yinjie Guan ◽  
George Bayliss ◽  
Shougang Zhuang

Sepsis-associated acute kidney injury (SA-AKI) is associated with high mortality rates, but clinicians lack effective treatments except supportive care or renal replacement therapies. Recently, histone deacetylase (HDAC) inhibitors have been recognized as potential treatments for acute kidney injury and sepsis in animal models; however, the adverse effect generated by the use of pan inhibitors of HDACs may limit their application in people. In the present study, we explored the possible renoprotective effect of a selective class IIa HDAC inhibitor, TMP195, in a murine model of SA-AKI induced by lipopolysaccharide (LPS). Administration of TMP195 significantly reduced increased serum creatinine and blood urea nitrogen levels and renal damage induced by LPS; this was coincident with reduced expression of HDAC4, a major isoform of class IIa HDACs, and elevated histone H3 acetylation. TMP195 treatment following LPS exposure also reduced renal tubular cell apoptosis and attenuated renal expression of neutrophil gelatinase-associated lipocalin and kidney injury molecule-1, two biomarkers of tubular injury. Moreover, LPS exposure resulted in increased expression of BAX and cleaved caspase-3 and decreased expression of Bcl-2 and bone morphogenetic protein-7 in vivo and in vitro; TMP195 treatment reversed these responses. Finally, TMP195 inhibited LPS-induced upregulation of multiple proinflammatory cytokines/chemokines, including intercellular adhesion molecule-1, monocyte chemoattractant protein-1, tumor necrosis factor-α, and interleukin-1β, and accumulation of inflammatory cells in the injured kidney. Collectively, these data indicate that TMP195 has a powerful renoprotective effect in SA-AKI by mitigating renal tubular cell apoptosis and inflammation and suggest that targeting class IIa HDACs might be a novel therapeutic strategy for the treatment of SA-AKI that avoids the unintended adverse effects of a pan-HDAC inhibitor.


PLoS ONE ◽  
2019 ◽  
Vol 14 (2) ◽  
pp. e0212818
Author(s):  
Gyu-Tae Shin ◽  
Hwa Joung Lee ◽  
Ji Eun Park

PLoS ONE ◽  
2016 ◽  
Vol 11 (5) ◽  
pp. e0155190 ◽  
Author(s):  
Li-Li Wen ◽  
Chien-Yu Lin ◽  
Hsiu-Chu Chou ◽  
Chih-Cheng Chang ◽  
Hau-Yin Lo ◽  
...  

2002 ◽  
Vol 168 (1) ◽  
pp. 248-252 ◽  
Author(s):  
K.K. Meldrum ◽  
K. Hile ◽  
D.R. Meldrum ◽  
J.A. Crone ◽  
J.P. Gearhart ◽  
...  

2001 ◽  
Vol 138 (5) ◽  
pp. 343-351 ◽  
Author(s):  
Rainer Oberbauer ◽  
Christoph Schwarz ◽  
Heinz M. Regele ◽  
Cornelia Hansmann ◽  
Timothy W. Meyer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document